USANA Health Sciences (NYSE:USNA) Hits New 12-Month Low – Should You Sell?

Shares of USANA Health Sciences, Inc. (NYSE:USNA) hit a new 52-week low on Thursday . The stock traded as low as $35.63 and last traded at $35.81, with a volume of 4493 shares. The stock had previously closed at $36.39.

Wall Street Analyst Weigh In

USNA has been the subject of a number of research reports. DA Davidson decreased their price objective on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, July 25th. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th.

USANA Health Sciences Stock Up 1.4 %

The company’s fifty day moving average price is $39.39 and its 200-day moving average price is $43.74. The stock has a market capitalization of $684.66 million, a PE ratio of 11.20, a price-to-earnings-growth ratio of 1.22 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. The company had revenue of $212.87 million for the quarter, compared to the consensus estimate of $218.64 million. During the same period last year, the business earned $0.89 EPS. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current year.

Insider Transactions at USANA Health Sciences

In related news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other USANA Health Sciences news, Director Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total value of $26,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Paul A. Jones sold 6,266 shares of the business’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The disclosure for this sale can be found here. Insiders sold a total of 7,940 shares of company stock valued at $311,670 in the last quarter. 0.33% of the stock is owned by insiders.

Institutional Investors Weigh In On USANA Health Sciences

Several large investors have recently bought and sold shares of the business. Pzena Investment Management LLC increased its position in USANA Health Sciences by 24.4% in the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after buying an additional 191,289 shares in the last quarter. Pacer Advisors Inc. increased its holdings in USANA Health Sciences by 14.3% in the 2nd quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock worth $21,143,000 after acquiring an additional 58,597 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in USANA Health Sciences by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 109,252 shares of the company’s stock worth $4,943,000 after acquiring an additional 27,053 shares during the period. Deerfield Management Company L.P. Series C boosted its position in shares of USANA Health Sciences by 297.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after purchasing an additional 22,251 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in shares of USANA Health Sciences in the second quarter worth $890,000. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.